InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by DONNELLY HOWARD W, Director. Officer active across 1 company, notably Angiodynamics INC. Cumulatively, 6 disclosures have been published. History available since 21 July 2021. The latest transaction was filed on 17 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Howard W. Donnelly is a Board Member at AngioDynamics Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the medical sector and knowledge of business operations are valuable assets to the board.